Company Overview of Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc., a drug discovery company, develops small molecule therapeutics for Alzheimer's and other neurodegenerative diseases. Its products targets the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. The company was incorporated in 2007 and is based in Pittsburgh, Pennsylvania.
2403 Sidney Street
Pittsburgh, PA 15203
Founded in 2007
Key Executives for Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Rempex Pharmaceuticals, Inc.||United States|
|Perlan Therapeutics, Inc.||United States|
|Elanco Animal Health, Inc.||United States|
|Interfacial Dynamics Corporation||United States|
|Sophion Bioscience Inc.||United States|
Recent Private Companies Transactions
December 20, 2012
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
- Charlotte, NC | JobvertisePosted: Nov 30
Sponsored Financial Commentaries
To contact Cognition Therapeutics, Inc., please visit www.cogrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.